Stock ABEO ABEONA THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Abeona Therapeutics Inc.

Equities

ABEO

US00289Y2063

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
4.06 USD -2.64% Intraday chart for Abeona Therapeutics Inc. -7.73% -18.96%
May. 16 Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating MT
May. 15 Transcript : Abeona Therapeutics Inc., Q1 2024 Earnings Call, May 15, 2024

Evolution of the average Target Price on Abeona Therapeutics Inc.

Price target over the last 5 years

History of analyst recommendation changes

46f151e.psw2BFYFAbeDAeSF7iEnCONfPEyUu3l9xnlN9FRvuc8.wbhvchxMSNa2Z9Xdn0JxT4Ivdn377zQ_gxg3v2AD4ZDWhVN2GUZ3_vNXoQ~8d5650d9773731ed23bb20682cf7154e

Analyst Recommendations on Abeona Therapeutics Inc.

Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating MT
Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $40 From $22, Maintains Overweight Rating MT
Alliance Global Starts Abeona Therapeutics at Buy With $20 Price Target MT
SVB Securities Adjusts Price Target on Abeona Therapeutics to $5 From $1, Maintains Market Perform Rating MT
Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $22 From $15, Reiterates Overweight Rating MT
SVB Leerink Downgrades Abeona Therapeutics to Market Perform From Outperform; Price Target is $1 MT
HC Wainwright Adjusts Abeona Therapeutics' Price Target to $4 From $5, Keeps Buy Rating MT
ABEONA THERAPEUTICS : HC Wainwright Adjusts Price Target on Abeona Therapeutics to $5 From $8, Maintains Buy Rating MT
ABEONA THERAPEUTICS : HC Wainwright Adjusts Abeona Therapeutics' Price Target to $8 From $11, Keeps at Buy MT
ABEONA THERAPEUTICS : B. Riley Adjusts Price Target on Abeona Therapeutics to $3 From $2, Reiterates Buy Rating MT
ABEONA THERAPEUTICS : Cantor Fitzgerald Upgrades Abeona Therapeutics to Overweight From Neutral; Price Target is $4 MT
ABEONA THERAPEUTICS : SVB Leerink Adjusts Abeona Therapeutics PT to $5 From $8, Maintains Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.06 USD
Average target price
19.5 USD
Spread / Average Target
+380.30%
High Price Target
36 USD
Spread / Highest target
+786.70%
Low Price Target
8 USD
Spread / Lowest Target
+97.04%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Abeona Therapeutics Inc.

Cantor Fitzgerald
Alliance Global Partners
SVB Securities LLC
SVB Leerink
HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ABEO Stock
  4. Consensus Abeona Therapeutics Inc.